Theratechnologies Inc T.TH

My opinion

[Momo25]

I am not a scientist and I don't care about the science per say. I care about the money I have invested in this company when the share was at  $15. I am still above 6$ a share in average . TH executives have no clue about the shareholders Return Of Investment. I see some of you trying to justify Paul's and the board attitudes. Those are  a gang of losers not business men.

[CreatingApe]

then sell your shares. And you are invested in a biotech and you dont care about the science? Lol

[Momo25]

First of all, When I decide to sell my shares, I will not ask for your permission. Secund, I am here to make money not to Learn about gene expression. third, if you don't know, biotechnology is one of the sector where people are making money, a lot of money except when investing in theratechnogies. Fourth, You are the ones who encourage the board in this silly attitude where communication

[CreatingApe]

its fascinating you are still invested in a company where you don't care about the science and you believe the CEO is a loser and not a businessman. Also I WILL tell you when to sell your shares momo. Lol PS go read spceo's post again, he literally said just that. The SP increase since paul took over looks great but he also began right about when the market was bottoming from the pandemic.

[Momo25]

@CreatingApe :3% down this morning. Enjoy!

[qwerty22]

UR an odd long    

[muslix1]

TH down 4% whit 9500 shares... very pathetic

[qwerty22]

You probably need to switch to US ticker, lot more action there.  

[Bucknelly21]

Even if results are good I bet Thtx will announce it right in the middle of a big market correction 

[SPCEO1]

If the results are good, it probably would only limit somewhat the reaction. Good cancer results get people's attention, as they should.

[qwerty22]

Hate to share this. Clearly these drugs are nothing to get excited about (same family of drugs as OBA) but could NASH sound any less appealing? "Crack­ing NASH has been the holy grail for years in liv­er drug de­vel­op­ment, but the field has so far proven a waste­land for biotech. One biotech is now of­fload­ing in-house clin­i­cal work for

[qwerty22]

On a brighter note. Cancer deal. "With a re­cent ap­proval for lung can­cer bis­pe­cif­ic ami­van­tam­ab, J&J is look­ing to build a fran­chise in that space with a grow­ing crop of drugs in the pipeline. The drug gi­ant has now tapped a fa­mil­iar part­ner to dri­ve that work ahead, and the pair is go

[qwerty22]

Different type of deal. https://www.globenewswire.com/news-release/2021/10/04/2307816/0/en/Centessa-Pharmaceuticals-Announces-300-Million-Financing-Agreement-with-Oberland-Capital.html

[qwerty22]

Enhurtu. Must be putting pressure on all those breast cancer only drug developers. Hopefully we get breast+another. "The FDA has grant­ed break­through des­ig­na­tion to As­traZeneca's and Dai­ichi Sanky­o's HER2 ADC En­her­tu, the com­pa­nies joint­ly an­nounced to­day. The BTD is for the treat­

[qwerty22]

One MD gushing over Enhurtu. https://www.medpagetoday.com/meetingcoverage/esmovideopearlsmetbreastca/94758

[Wino115]

The extension of PFS to 27 months is impressive.  This is 2L and HER2+ breast cancer is about 20% of cases. Great news for patients.  It seems it's becoming the standard for HER2+. Given the targeting issues, I guess Enhertu will only work for the HER2+ subset so may not be useful for THTX to attach for all solid tumors in 4L setting.  But those numbers would be something to

[qwerty22]

That's true. Just her2+ so tnbc is unaffected. There are an awful lot of ADC developers that are using trastuzumab as their antibody, they will be competing with Enhurtu, makes their prospects more difficult. I guess it could cause a shake up or shake out in the sector, maybe there will be more interest in other target. (Sortilin anybody???). It would be interesting to see if they start

[juniper88]

Can you tell me what the ROI has been since Paul became CEO?

[SPCEO1]

I beleive Paul formally started at TH on 4/1/20, which of course was right after the market bottomed in the pandemic scare. The stock price closed at US$1.58 on 4/1/20 so the stock is now up 138% since then. But clearly, Paul got a lucky break in that starting point and the recovery in the stock priceis not something he get full credit for. Still, he should get considerable credit. 

[realitycheck4u]

This post has been removed in accordance with Community Policy

[LouisW]

When i feel frustrated, i just do literature survey to see if there's any interesting paper is published. I have read literally all of the literature related to cancer/SORT1 and NASH (Only 18 articles since 2000). That convinced me to hold the shares tightly again and again. BTW, Paul will attend the China Biotech forum today, so i believe he will bring us a good news regarding the partnership

[jeffm34]

Realitycheck4u, since you've been here for a long while how many times have you thought "just another few months" ?  Through the false sales estimates, the new sales team, European approval, F8, IV push, NASH trial starting, NASH partnership coming, Oncology results in 2021, oncology results in early 2022 now, if there is no efficacy to report in part 1 then we wait another 6

[realitycheck4u]

This post has been removed in accordance with Community Policy

[PinnacleX]

Finally, a guy with common sense.  The rest of the fanboys will defend this when its at 10 cents, the same way they are now. 

[muslix1]

F... you are still alive... welcome back... we need you

[FredTheVoice]

F... you are still alive... welcome back... we need you - MUSLIX. WOW ! Thats very funny..... I needed that ! Im thinking of doing the same, TH is a good buy at this price. Cheers my friend; and thanks for the laughters ! FTV.

[muslix1]

Happy to see you it's like the canadian  hockey club... There is no easy day... lol

[ANALIAS00]

Investing in biotechnologies is close to be like investigating in minings. It is a very speculative investment. As a "wise" and "smart" invester we should not be frustrated if investing in biotechnologies since we should be investing a very low percentage of our money in this risky industry. So, if you are frustrated, it just mean that you had invested to much of your money. Am